眼科用手術器具市場のレポート (2023年)：世界市場の分析 (2022年～2028年)

最新情報

当レポートでは、世界の眼科用手術器具市場における様々な持続可能性に関する取り組みや、使い捨て型器具による手術室の廃棄物を減らすためのESCRSとAAOからの提言について最新の情報を提供しています。持続可能性に関する新たな章では、メーカーが直面する課題に注目し、その取り組みが各製品カテゴリーの将来の売上に与える影響の予測を示す新たな評価尺度を掲載しています。

当レポートでは、外科的処置の予測を眼科の専門分野ごとの予測と結びつけています。また、世界の独占的なプロバイダーを生み出した、最新の企業買収・統合の動きも掲載しています。

当レポートでは、2023年時点の世界の眼科用手術器具市場（再利用型・使い捨て型の両方）について包括的な分析を行い、今後5年間の市場業績を予測しています。また、重要動向、市場促進要因、将来の成功のための主な要因について考察しています。当レポートでは、世界の眼科手術と手術件数の概要、および最も一般的に行われている眼科手術である白内障手術の提供者について詳しく解説しています。製品需要は数量と金額で予測され、市場シェアは製品カテゴリー別に分析されています。市場セグメンテーションでは、31社の企業プロファイル（製品、戦略的市場ポジション、背景、展望など）を掲載し、市場セグメントに関わる85社をリストアップしています。

目次

当レポートでは、再利用型・使い捨て型器具の市場動向について、読者の理解に深みと背景を与えることを目的としています。内容は以下の通りです：

• 再利用型・使い捨て型眼科手術製品の概要。
• 再利用型・使い捨て型眼科手術製品業界の企業プロファイル。
• 世界の白内障の発症率、および白内障手術の統計に関する情報。
• 世界の白内障手術件数の推定値・予測値 (今後5年間分)。
• 屈折レンズ交換術に関する考察。
• 眼科手術の提供者に関する情報。
• 米国のASC (外来手術センター) と、世界の白内障手術の提供者。
• 世界の白内障・緑内障の治療法のレビュー。
• 世界の眼科医の概況。

What's New:

The new "2023 Ophthalmic Surgical Instruments Market Report" provides the latest coverage of various sustainability initiatives and recommendations from the ESCRS and AAO to reduce operating room waste caused by disposable devices. A new chapter on sustainability looks at the challenges that manufacturers face and includes a new rating scale showing the predicted impact of these initiatives on future sales of each product category.

The report connects our surgical procedure forecast by ophthalmic subspecialty to our forecast for surgical instruments. It also lists the latest company acquisitions and consolidations among market competitors that have created globally dominant providers.

The report provides a comprehensive analysis of the 2023 global market for ophthalmic surgical instruments-both reusable and disposable-and forecasts market performance over the next five years. Important trends, market drivers, and key factors for future success are discussed. The report offers an overview of ophthalmic surgeries and surgery volume worldwide, as well as an in-depth look at providers of cataract surgery, the most commonly performed ophthalmic surgery. Product demand is forecast in units and dollars, and market shares are analyzed by product category. The report profiles 31 market competitors-with discussion of their products, strategic market position, background, and outlook-and lists 85 total companies involved in the market segment.

Contents:

The report is designed to provide depth and context to the reader's understanding of market dynamics in the reusable and disposable instrument market. Coverage includes:

• Descriptions of reusable and disposable ophthalmic surgical products.

• Profiles of companies in the reusable and disposable ophthalmic surgical products industry.

• Information on the global incidence of cataracts and global statistics on cataract surgeries.

• Current estimates and five-year forecasts for cataract surgery volume worldwide.

• Discussion of refractive lens exchange procedures.

• Information on ophthalmic surgery providers.

• US ASCs and cataract surgery providers worldwide.

• Review of global cataract and glaucoma treatment methods.

• Global overview of ophthalmologists.

Author Profile:

William Freeman

Bill Freeman has more than 35 years of experience developing, manufacturing, and marketing cataract surgery products. He has held key executive positions at four firms that produce ophthalmic surgical devices.

Bill's career in ophthalmology began in the 1970s. As president of Cavitron Surgical Systems, he worked with Dr. Charles Kelman in developing and marketing the world's first phacoemulsifier system. While highly controversial in the 1970s, phacoemulsification gradually became the preferred cataract removal technique in the early 1980s. For many years, Cavitron led the cataract instrumentation market.

CooperVision purchased Cavitron in the early 1980s, and Bill joined the company as president of the surgical division. CooperVision expanded its product line to include a wide variety of cataract surgical products-IOLs, viscoelastic solutions, disposable devices, lasers, and custom packs-and became the market leader in many product categories.

In 1989, Alcon acquired CooperVision in an effort to build a strong presence in cataract surgical devices. Bill joined Alcon as general manager of the Irvine Technology Center, where a number of the company's cataract devices, including the Legacy 20000 phacoemulsifier and a broad line of disposable items, were designed and manufactured.

Bill remained with Alcon until 1995. He then joined Mentor Ophthalmics as president of the ophthalmology division. At Mentor, he was responsible for the company's ophthalmic products including IOLs, cautery devices, and surgical instruments.

After leaving Mentor in 1999, Bill joined Market Scope in 2000 and now serves as executive vice president focusing on ophthalmic surgical cataract, retinal and glaucoma devices.